INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

24,511 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
25
DC
Duncan Charles CliffDirector
VNDAVanda Pharmaceuticals Inc.
Open-market purchase
BUY$13K
3,447 sh
Nov 4, 2026Nov 5, 2026
Page 19 of 613
← PrevNext →
traded Nov 4, 2026
+1d
SEC Form 4

Evidence

25
WL
West Michael LCEO - Moody's Ratings
MCOMOODYS CORP /DE/
Open-market sale
SELL$103K
195 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

25
PR
Price Teddy RayDirector
RRBIRED RIVER BANCSHARES INC
Open-market purchase
BUY$95K
878 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

24
RT
2018 Reed Dynasty Trust10% Owner
ARHSArhaus, Inc.
Open-market sale · 10b5-1 plan
SELL$604K
50.3K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

24
MG
Magrath GeorgeDirector, Chief Executive Officer
IRDOpus Genetics, Inc.
Open-market sale
SELL$110K
28.3K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

24
MF
Montoya Michael FChief Technology Ops Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$184K
560 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

24
NL
Nies Gerald LeeDirector
RVSBRIVERVIEW BANCORP INC
Open-market sale
SELL$111K
18.0K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

24
DL
Dunkel David LDirector
KFRCKFORCE INC
Open-market sale
SELL$58K
1,000 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

24
MA
Miller Craig AndrewSVP, Pres Viasat Government
VSATVIASAT INC
Open-market sale · 10b5-1 plan
SELL$750K
10.7K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

24
Maria Elvira SalazarRSelf
PGPROCTER & GAMBLE Co
Purchase
BUY$1,001 – $15KOct 23, 2026Nov 5, 2026
traded Oct 23, 2026
+13dHouse PTR

Evidence

24
Maria Elvira SalazarRSelf
PGPROCTER & GAMBLE Co
Purchase
BUY$1,001 – $15KOct 23, 2026Nov 5, 2026
traded Oct 23, 2026
+13dHouse PTR

Evidence

24
MP
Moran Timothy P.Chief Business Officer
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
Open-market sale
SELL$94K
3,192 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

24
RP
Reed John PDirector, CEO and Chairman, 10% Owner
ARHSArhaus, Inc.
Open-market sale · 10b5-1 plan
SELL$696K
57.9K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

24
DL
Dunkel David LDirector
KFRCKFORCE INC
Open-market sale
SELL$58K
1,000 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

23
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$886K
9,650 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

23
RA
Rodriguez Carlos ADirector
ADPAUTOMATIC DATA PROCESSING INC
Open-market sale · 10b5-1 plan
SELL$88K
288 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
RA
Rodriguez Carlos ADirector
ADPAUTOMATIC DATA PROCESSING INC
Open-market sale · 10b5-1 plan
SELL$138K
455 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
EM
Ehrlichman MattDirector, CEO, CHAIRMAN AND FOUNDER, 10% Owner
PRCHPorch Group, Inc.
Open-market sale · 10b5-1 plan
SELL$215K
10.0K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

23
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$337K
3,622 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
Saba Capital Management, L.P.10% Owner
ECATBlackRock ESG Capital Allocation Term Trust
Open-market sale
SELL$1.31M
95.1K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
QV
Qiming Corporate GP VI, Ltd.10% Owner
ALMRAlamar Biosciences, Inc.
Open-market sale
SELL$2.16M
72.3K sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

23
RA
Rodriguez Carlos ADirector
ADPAUTOMATIC DATA PROCESSING INC
Open-market sale · 10b5-1 plan
SELL$85K
280 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
RA
Rodriguez Carlos ADirector
ADPAUTOMATIC DATA PROCESSING INC
Open-market sale · 10b5-1 plan
SELL$68K
228 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
CD
Campbell Richard DDirector
SPFISOUTH PLAINS FINANCIAL, INC.
Open-market sale
SELL$785K
17.8K sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC Form 4

Evidence

23
RA
Rodriguez Carlos ADirector
ADPAUTOMATIC DATA PROCESSING INC
Open-market sale · 10b5-1 plan
SELL$55K
180 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
WM
Whalen Chad MichaelEVP, Worldwide Sales
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$79K
240 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

23
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Open-market sale · 10b5-1 plan
SELL$569K
6,175 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
RA
Rodriguez Carlos ADirector
ADPAUTOMATIC DATA PROCESSING INC
Open-market sale · 10b5-1 plan
SELL$60K
198 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
RP
Reed John PDirector, CEO and Chairman, 10% Owner
ARHSArhaus, Inc.
Open-market sale · 10b5-1 plan
SELL$1.17M
89.5K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
CD
Campbell Richard DDirector
SPFISOUTH PLAINS FINANCIAL, INC.
Open-market sale
SELL$700K
15.9K sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
RA
Rodriguez Carlos ADirector
ADPAUTOMATIC DATA PROCESSING INC
Open-market sale · 10b5-1 plan
SELL$54K
180 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
RA
Rodriguez Carlos ADirector
ADPAUTOMATIC DATA PROCESSING INC
Open-market sale · 10b5-1 plan
SELL$61K
199 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

23
WM
Whalen Chad MichaelEVP, Worldwide Sales
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$239K
720 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC Form 4

Evidence

22
PR
Price Teddy RayDirector
RRBIRED RIVER BANCSHARES INC
Open-market purchase
BUY$1,509
14 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

22
AL
Alexander Patrick LDirector
LARKLANDMARK BANCORP INC
Open-market sale
SELL$11K
350 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC Form 4

Evidence

22
CG
Canup Edward GCHIEF BANKING OFFICER
CBANCOLONY BANKCORP INC
Open-market purchase
BUY$21K
1,000 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

22
PR
Price Teddy RayDirector
RRBIRED RIVER BANCSHARES INC
Open-market purchase
BUY$16K
153 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

22
OM
Opaleye Management Inc.10% Owner
GRCEGrace Therapeutics, Inc.
Open-market purchase
BUY$5,478
3,087 sh
Nov 5, 2026Nov 5, 2026
traded Nov 5, 2026
+0dSEC Form 4

Evidence

22
OM
Opaleye Management Inc.10% Owner
GRCEGrace Therapeutics, Inc.
Open-market purchase
BUY$9,060
5,027 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence

22
Saba Capital Management, L.P.10% Owner
GRXGabelli Healthcare & WellnessRx Trust
Open-market purchase
BUY$7,301
700 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC Form 4

Evidence